SIGNET RING CELL ADENOCARCINOMA
Clinical trials for SIGNET RING CELL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SIGNET RING CELL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for SIGNET RING CELL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a chemo-immunotherapy combo tame hard-to-treat colorectal cancer?
Disease control OngoingThis study tests whether a short course of chemotherapy can make a type of advanced colorectal cancer (pMMR/MSS) more responsive to immunotherapy. The goal is to achieve long-term disease control or even eliminate tumors. About 80 adults with untreated, spread colorectal cancer w…
Matched conditions: SIGNET RING CELL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: University Hospital, Akershus • Aim: Disease control
Last updated May 17, 2026 11:36 UTC
-
Virus-Immunotherapy combo targets tough skin cancers
Disease control OngoingThis study tests a two-step treatment for people with rare skin cancers or certain lymphomas that haven't improved with standard care. First, patients receive a virus-based drug (talimogene laherparepvec) injected into tumors to help the immune system recognize and attack cancer …
Matched conditions: SIGNET RING CELL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:47 UTC